Mackenzie Financial Portfolio holdings
AUM
$77.2B
1-Year Return
22.51%
This Quarter Return
+8.99%
1 Year Return
+22.51%
3 Year Return
+61.14%
5 Year Return
+128.52%
10 Year Return
+216.87%
AUM
$71.9B
AUM Growth
+$4.56B
(+6.8%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
22.04%
Holding
1,713
New
179
Increased
656
Reduced
640
Closed
139
Top Buys
| 1 |
Stryker
SYK
|
$306M |
| 2 |
Mastercard
MA
|
$276M |
| 3 |
Alcon
ALC
|
$231M |
| 4 |
Thermo Fisher Scientific
TMO
|
$230M |
| 5 |
Apple
AAPL
|
$191M |
Top Sells
| 1 |
Visa
V
|
$392M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$264M |
| 3 |
Nutrien
NTR
|
$248M |
| 4 |
Becton Dickinson
BDX
|
$189M |
| 5 |
Accenture
ACN
|
$146M |
Sector Composition
| 1 | Financials | 21.61% |
| 2 | Technology | 20.85% |
| 3 | Industrials | 12.31% |
| 4 | Healthcare | 9.9% |
| 5 | Energy | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Hewlett Packard
HPE
$31B
| $60.1M | 0.08% |
2,937,503
+851,947
| +41% | +$17.4M |
|
202
HDFC Bank
HDB
$361B
| $59.5M | 0.08% |
951,159
+26,350
| +3% | +$1.65M |
|
203
RB Global
RBA
$21.4B
| $59.4M | 0.08% |
737,652
+96,570
| +15% | +$7.77M |
|
204
Sabesp
SBS
$15.8B
| $59.3M | 0.08% |
3,586,937
-639,533
| -15% | -$10.6M |
|
205
Boston Scientific
BSX
$159B
| $59M | 0.08% |
703,940
+36,745
| +6% | +$3.08M |
|
206
Regeneron Pharmaceuticals
REGN
$60.8B
| $58.9M | 0.08% |
55,992
-1,972
| -3% | -$2.07M |
|
207
FedEx
FDX
$53.7B
| $58.6M | 0.08% |
214,166
+5,434
| +3% | +$1.49M |
|
208
Caterpillar
CAT
$198B
| $58M | 0.08% |
148,354
-30,606
| -17% | -$12M |
|
209
Republic Services
RSG
$71.7B
| $57.4M | 0.08% |
285,988
+17,377
| +6% | +$3.49M |
|
210
Bombardier Recreational Products
DOOO
$4.78B
| $56.8M | 0.08% |
954,614
+556,156
| +140% | +$33.1M |
|
|
DQ
211
Daqo New Energy
DQ
$1.96B
| $56.4M | 0.08% |
2,767,554
+270,557
| +11% | +$5.51M |
|
212
Fiserv
FI
$73.4B
| $55.8M | 0.08% |
310,666
-38,484
| -11% | -$6.91M |
|
213
Travelers Companies
TRV
$62B
| $54.9M | 0.08% |
234,681
+956
| +0.4% | +$224K |
|
214
Amgen
AMGN
$153B
| $54.7M | 0.08% |
169,838
-2,596
| -2% | -$836K |
|
215
UBS Group
UBS
$128B
| $54.4M | 0.08% |
1,763,230
-85,688
| -5% | -$2.64M |
|
216
Invesco QQQ Trust
QQQ
$368B
| $53.7M | 0.07% |
110,096
-1,577
| -1% | -$770K |
|
217
Cboe Global Markets
CBOE
$24.3B
| $53.3M | 0.07% |
260,221
+39,131
| +18% | +$8.02M |
|
218
Maravai LifeSciences
MRVI
$363M
| $52.9M | 0.07% |
6,363,412
+502,771
| +9% | +$4.18M |
|
219
ResMed
RMD
$40.6B
| $51.9M | 0.07% |
212,433
+45,278
| +27% | +$11.1M |
|
220
Target
TGT
$42.3B
| $51.6M | 0.07% |
331,041
+11,819
| +4% | +$1.84M |
|
221
Dominion Energy
D
$49.7B
| $51.5M | 0.07% |
890,601
+37,710
| +4% | +$2.18M |
|
222
PNC Financial Services
PNC
$80.5B
| $51.4M | 0.07% |
277,816
+75,669
| +37% | +$14M |
|
223
Gilead Sciences
GILD
$143B
| $50.8M | 0.07% |
606,230
-12,772
| -2% | -$1.07M |
|
224
BP
BP
$87.4B
| $50.7M | 0.07% |
1,616,174
+111,437
| +7% | +$3.5M |
|
225
HCA Healthcare
HCA
$98.5B
| $50.5M | 0.07% |
124,284
+43,249
| +53% | +$17.6M |
|